Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The new hair product quickly reduces hair shedding in women.

Telogen effluvium is a common hair loss condition requiring careful diagnosis and treatment.

Hair shedding after COVID-19 is more linked to the disease's severity and inflammation rather than hormones, with women at higher risk.

Hair shedding is common in GLP-1 users, affecting treatment adherence.

The document says there are five types of hair loss conditions and different causes, including drugs.

Telogen effluvium is a condition that causes temporary hair loss.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Hair root dermoscopy is a simple, noninvasive tool to diagnose telogen effluvium.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

A 45-year-old woman experienced excessive hair shedding beyond the normal range.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Crash dieting can cause temporary hair loss due to not getting enough energy for hair growth.

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.

Hair shedding in children is normal and increases with age.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Scientists made a mouse that can be made to lose hair and then grow it back.

A new topical solution safely reduces hair shedding by 38% on average by tightening a muscle in the scalp.

The hair shedding scale accurately identifies abnormal hair shedding in women with long hair, with grades 5 and 6 indicating excessive shedding.

The HSVS-A is an effective tool for quickly screening hair shedding in Asian women.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Reassurance and counseling are key in managing acute telogen effluvium, with supplements possibly offering a placebo effect.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

A woman had temporary hair loss due to stress from a spinal cord injury.

A woman's temporary hair loss after face lift surgery stopped on its own, and hair grew back.

Newborns can experience temporary hair loss in bands, unrelated to sleeping position.

The conclusion is that exogen is a unique hair cycle phase and the new sampling method specifically targets this stage, which may help in future hair loss research.

Hair growth and shedding involve specific cell changes and gene roles.